- Home
- Companies
- united kingdom
- phenotyping
Show results for
Refine by
Phenotyping Suppliers In United Kingdom
26 companies found
Premium
based inBurwell, UNITED KINGDOM
Delta-T offers a wide range of data loggers and sensors able to measure and record hydrological, meteorological and other environmental parameters. Our products provide direct measurements of the forces and effects that renewable energy and other ...
based inOxford, UNITED KINGDOM
ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. We offer unique solutions for preclinical and clinical immunology research, including a comprehensive and integrated antigen ...
Pro5® MHC Class I Pentamers the most consistent, most published commercial technology for detecting antigen-specific CD8+ T cells. Pro5® MHC Pentamer. The beautiful rational design of Pro5® MHC Pentamers presents five MHC peptide ...
based inSomerset, NEW JERSEY (USA)
As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...
At Catalent, our methodologies work toward reducing the overall costs and time it takes to get your product to the clinic. With decades of experience in analytical development, we understand our clients’ needs, the current regulatory ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
Both models are iPSC derived allowing gene-edited lines to be engineered using CRISPR/Cas9 for direct comparison between WT and mutant phenotypes after differentiation. Targeted mutations can model retinopathies, more specifically ...
based inLittle Chesterford, UNITED KINGDOM
The microbiome represents a paradigm shift that affects every aspect of biomedicine: our gut bacteria control health, disease and drug response throughout the body, and can themselves be a novel type of medicine. The microbiome therefore has the ...
Thus metagenomics routinely can classify only 50 % of gut bacterial sequences, meaning that a very large fraction of gut bacteria are not seen, compromising the association between particular bacteria and biology or patient ...
based inGlasgow, UNITED KINGDOM
Our mission is to enhance decision making within R&D by leveraging Digital Pathology to deliver robust data and actionable insights. OracleBio is a global leader in quantitative digital pathology, providing image analysis services to Pharma and ...
Adding value to Immuno-Oncology studies with Quantitative Digital Pathology. Quantitative Digital Pathology provides deep insights into the tumor microenvironment (TME), a knowledge which is crucial for understanding the mechanism of action of new ...
based inLondon, UNITED KINGDOM
We built an online platform through which we wanted to see a change in the way healthcare was delivered to our close family members. Now we want to change the status quo. We believe that the future of healthcare lies in precision medicine coupled ...
based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
based inShirley, NEW YORK (USA)
Creative Bioarray is a leading customer-centered biotechnology company and a pioneer with the latest technology of cell patterning. Creative Bioarray has an experienced expert team and is committed to providing comprehensive services and customized ...
Immortalized cell lines and services are of ever-increasing importance in various aspects of biomedicine, toxicology and biotechnology. The cells can be used as model systems in phenotypic and drug screening, high content analysis, ...
based inNottinghamshire, UNITED KINGDOM
NanoFCM is a company focused on high‐sensitivity flow cytometry and analysis of nanoparticles such as extracellular vesicles, viruses, and nanomedicines, but the public homepage content available right now is minimal and does not provide further ...
based inGiesbeek, NETHERLANDS
Royal Eijkelkamp makes a difference worldwide by developing, producing and delivering solutions for soil and water research. Our innovative solutions, coupled with the knowledge and expertise of our soil and water specialists at Royal Eijkelkamp, ...
based inSanta Clara, CALIFORNIA (USA)
For more than 40 years, Agilent Technologies has been the leading provider of solutions for the detection, identification, and characterization of chemical and biological compounds. From environmental testing to semiconductor manufacturing, ...
Cytation 5 combines automated microscopy and conventional microplate detection in a configurable, upgradable platform. The microscopy module offers up to 60x magnification in fluorescence, brightfield, high contrast brightfield, color brightfield, ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Our mission at Alcyomics is to provide novel solutions for the assessment of safety and efficacy of pharmaceuticals, cosmetics and chemicals. As a service provider Alcyomics aspires to take the lead in providing unique screening services enabling ...
Assessment of immune activation: Alcyomics has a wide range of cell phenotypic services for your research needs, to benefit both drug discovery and validation. With our in-house state-of-the-art instrumentation, we can analyse and ...
based inOxford, UNITED KINGDOM
We specialize in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions. Since launching as a spin-out from the University of Oxford, we have developed award-winning, AI-powered imaging biomarkers ...
There is a growing need for more accurate and reproducible assessment and quantification of Interstitial Lung Disease. Brainomix’ e-ILD solution has been trained to characterize and quantify pulmonary fibrosis and other characteristics using ...
based inOxford, UNITED KINGDOM
Founded in 2012, we are the leading pharmatech company and the first to automate drug discovery. As a full stack AI drug discovery company, we generate our own data before combining the analytical power of AI with the creativity and expertise of our ...
Only with continual feedback between experiment and prediction can machine learning models be refined and deliver against complex therapeutic ...
based inOxford, UNITED KINGDOM
Orbit was founded By Professor Terry Rabbitts and Professor Graham Ogg in 2015 as a spin-out from the University of Oxford. The company’s focus is to identify therapeutic peptides using its unique peptide display platform. In 2021 the organisation ...
Orbit presents DNA and peptide on the surface of a microbead. This allows for unbiased libraries and a tunable multivalent display that gives access to huge chemical diversity. Our display technology can deal with unnatural amino acids and ...
based inCharlottesville, VIRGINIA (USA)
Indoor Biotechnologies is an immunodiagnostics and biotechnology company specializing in manufacturing innovative products for investigating allergy and asthma. The company is recognized as the world leader in assessment of environmental exposure to ...
based inCambridge, UNITED KINGDOM
CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of ...
Generate human-specific pre-clinical safety and efficacy data with pioneering PhysioMimix single- and multi-organ-on-a-chip ...
based inOxford, UNITED KINGDOM
As a leading global provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient, every time. The quality and innovation built into our products for NGS, ...
The CKS1B/CDKN2C product consists of a 182kb probe, labelled in red, covering the entire CKS1B gene and flanking regions, including the PYGO2 and ZBTB7B genes, and a green probe covering a 170kb region, including the entire CDKN2C gene, the D1S1661 ...